Literature DB >> 26362351

Disruption of phactr-1 pathway triggers pro-inflammatory and pro-atherogenic factors: New insights in atherosclerosis development.

Rafika Jarray1, Serena Pavoni2, Lucia Borriello3, Barbara Allain3, Nicolas Lopez4, Sara Bianco3, Wang-Qing Liu3, Denis Biard2, Luc Demange5, Olivier Hermine6, Christiane Garbay3, Françoise Raynaud7, Yves Lepelletier8.   

Abstract

Significant interest has recently emerged for phosphatase and actin regulatory protein (PHACTR1) gene in heart diseases prognosis. However, the functional role of phactr-1 protein remains elusive in heart related-diseases such as atherosclerosis, coronary artery calcification, ischaemic stroke, coronary artery stenosis and early-onset myocardial infarction. Phactr-1 is directly regulated by vascular endothelial growth factor A165 (VEGF-A165) through VEGF receptor 1 (VEGR-1) and Neuropilin-1 (NRP-1). Using an antagonist peptide approach to inhibit the interaction of VEGF-A165 to NRP-1 and VEGF-R1, we highlighted the importance of both cysteine residues located at the end of VEGF-A165 exon-7 and at the exon-8 to generate functional peptides, which decreased Phactr-1 expression. Here, we report original data showing Phactr-1 down-expression induces the expression of Matrix Metalloproteinase (MMP) regulators such as Tissue inhibitor of metalloproteinase (TIMP-1/-2) and Reversion-inducing-cysteine-rich protein with kazal motifs (RECK). Furthermore, focal adhesion kinases (FAK/PYK2/PAXILLIN) and metabolic stress (AMPK/CREB/eNOS) pathways were inhibited in endothelial cells. Moreover, the decrease of phactr-1 expression induced several factors implicated in atherosclerotic events such as oxidized low-density lipoprotein receptors (CD36, Clusterin, Cadherin-13), pro-inflammatory proteins including Thrombin, Thrombin receptor 1 (PAR-1), A Disintegrin And Metalloprotease domain-9/-17 (ADAM-9/-17), Trombospondin-2 and Galectin-3. Besides, Phactr-1 down-expression also induces emerging atherosclerosis biomarkers such as semicarbazide-sensitive amine oxidase (SSAO) and TGF-beta-inducible gene h3 (βIG-H3). In this report, we show for the first time the direct evidence of the phactr-1 biological function in the regulation of pro-atherosclerotic molecules. This intriguing result strengthened heart diseases PHACTR-1 single-nucleotide polymorphisms (SNP) correlation. Taken together, our result highlighted the pivotal role of phactr-1 protein in the pathogenesis of atherosclerosis.
Copyright © 2015 Elsevier B.V. and Société Française de Biochimie et Biologie Moléculaire (SFBBM). All rights reserved.

Entities:  

Keywords:  Atherosclerotic factors; MMP regulators; Neuropilin; Phactr-1; VEGF

Mesh:

Substances:

Year:  2015        PMID: 26362351     DOI: 10.1016/j.biochi.2015.09.008

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  12 in total

1.  A Genetic Variant Associated with Five Vascular Diseases Is a Distal Regulator of Endothelin-1 Gene Expression.

Authors:  Rajat M Gupta; Joseph Hadaya; Aditi Trehan; Seyedeh M Zekavat; Carolina Roselli; Derek Klarin; Connor A Emdin; Catharina R E Hilvering; Valerio Bianchi; Christian Mueller; Amit V Khera; Russell J H Ryan; Jesse M Engreitz; Robbyn Issner; Noam Shoresh; Charles B Epstein; Wouter de Laat; Jonathan D Brown; Renate B Schnabel; Bradley E Bernstein; Sekar Kathiresan
Journal:  Cell       Date:  2017-07-27       Impact factor: 41.582

2.  Causal Gene Confusion: The Complicated EDN1/PHACTR1 Locus for Coronary Artery Disease.

Authors:  Rajat M Gupta
Journal:  Arterioscler Thromb Vasc Biol       Date:  2022-04-07       Impact factor: 10.514

3.  Transcription of the Envelope Protein by 1-L Protein-RNA Recognition Code Leads to Genes/Proteins That Are Relevant to the SARS-CoV-2 Life Cycle and Pathogenesis.

Authors:  Jozef Nahalka
Journal:  Curr Issues Mol Biol       Date:  2022-02-06       Impact factor: 2.976

4.  Deficiency of macrophage PHACTR1 impairs efferocytosis and promotes atherosclerotic plaque necrosis.

Authors:  Canan Kasikara; Maaike Schilperoort; Brennan Gerlach; Chenyi Xue; Xiaobo Wang; Ze Zheng; George Kuriakose; Bernhard Dorweiler; Hanrui Zhang; Gabrielle Fredman; Danish Saleheen; Muredach P Reilly; Ira Tabas
Journal:  J Clin Invest       Date:  2021-04-15       Impact factor: 14.808

5.  PHACTR1 Is a Genetic Susceptibility Locus for Fibromuscular Dysplasia Supporting Its Complex Genetic Pattern of Inheritance.

Authors:  Soto Romuald Kiando; Nathan R Tucker; Luis-Jaime Castro-Vega; Alexander Katz; Valentina D'Escamard; Cyrielle Tréard; Daniel Fraher; Juliette Albuisson; Daniella Kadian-Dodov; Zi Ye; Erin Austin; Min-Lee Yang; Kristina Hunker; Cristina Barlassina; Daniele Cusi; Pilar Galan; Jean-Philippe Empana; Xavier Jouven; Anne-Paule Gimenez-Roqueplo; Patrick Bruneval; Esther Soo Hyun Kim; Jeffrey W Olin; Heather L Gornik; Michel Azizi; Pierre-François Plouin; Patrick T Ellinor; Iftikhar J Kullo; David J Milan; Santhi K Ganesh; Pierre Boutouyrie; Jason C Kovacic; Xavier Jeunemaitre; Nabila Bouatia-Naji
Journal:  PLoS Genet       Date:  2016-10-28       Impact factor: 5.917

6.  PHACTR1 splicing isoforms and eQTLs in atherosclerosis-relevant human cells.

Authors:  Valérie-Anne Codina-Fauteux; Mélissa Beaudoin; Simon Lalonde; Ken Sin Lo; Guillaume Lettre
Journal:  BMC Med Genet       Date:  2018-06-08       Impact factor: 2.103

7.  Trans-ethnic association study of blood pressure determinants in over 750,000 individuals.

Authors:  Ayush Giri; Jacklyn N Hellwege; Jacob M Keaton; Jihwan Park; Chengxiang Qiu; Helen R Warren; Eric S Torstenson; Csaba P Kovesdy; Yan V Sun; Otis D Wilson; Cassianne Robinson-Cohen; Christianne L Roumie; Cecilia P Chung; Kelly A Birdwell; Scott M Damrauer; Scott L DuVall; Derek Klarin; Kelly Cho; Yu Wang; Evangelos Evangelou; Claudia P Cabrera; Louise V Wain; Rojesh Shrestha; Brian S Mautz; Elvis A Akwo; Muralidharan Sargurupremraj; Stéphanie Debette; Michael Boehnke; Laura J Scott; Jian'an Luan; Jing-Hua Zhao; Sara M Willems; Sébastien Thériault; Nabi Shah; Christopher Oldmeadow; Peter Almgren; Ruifang Li-Gao; Niek Verweij; Thibaud S Boutin; Massimo Mangino; Ioanna Ntalla; Elena Feofanova; Praveen Surendran; James P Cook; Savita Karthikeyan; Najim Lahrouchi; Chunyu Liu; Nuno Sepúlveda; Tom G Richardson; Aldi Kraja; Philippe Amouyel; Martin Farrall; Neil R Poulter; Markku Laakso; Eleftheria Zeggini; Peter Sever; Robert A Scott; Claudia Langenberg; Nicholas J Wareham; David Conen; Colin Neil Alexander Palmer; John Attia; Daniel I Chasman; Paul M Ridker; Olle Melander; Dennis Owen Mook-Kanamori; Pim van der Harst; Francesco Cucca; David Schlessinger; Caroline Hayward; Tim D Spector; Marjo-Riitta Jarvelin; Branwen J Hennig; Nicholas J Timpson; Wei-Qi Wei; Joshua C Smith; Yaomin Xu; Michael E Matheny; Edward E Siew; Cecilia Lindgren; Karl-Heinz Herzig; George Dedoussis; Joshua C Denny; Bruce M Psaty; Joanna M M Howson; Patricia B Munroe; Christopher Newton-Cheh; Mark J Caulfield; Paul Elliott; J Michael Gaziano; John Concato; Peter W F Wilson; Philip S Tsao; Digna R Velez Edwards; Katalin Susztak; Christopher J O'Donnell; Adriana M Hung; Todd L Edwards
Journal:  Nat Genet       Date:  2018-12-21       Impact factor: 38.330

8.  Genetic and environmental risk factors for atherosclerosis regulate transcription of phosphatase and actin regulating gene PHACTR1.

Authors:  Michael E Reschen; Da Lin; Anil Chalisey; Elizabeth J Soilleux; Christopher A O'Callaghan
Journal:  Atherosclerosis       Date:  2016-05-02       Impact factor: 5.162

9.  The Genetic Architecture of Diet-Induced Hepatic Fibrosis in Mice.

Authors:  Simon T Hui; Zeyneb Kurt; Iina Tuominen; Frode Norheim; Richard C Davis; Calvin Pan; Darwin L Dirks; Clara E Magyar; Samuel W French; Karthickeyan Chella Krishnan; Simon Sabir; Francisco Campos-Pérez; Nahum Méndez-Sánchez; Luis Macías-Kauffer; Paola León-Mimila; Samuel Canizales-Quinteros; Xia Yang; Simon W Beaven; Adriana Huertas-Vazquez; Aldons J Lusis
Journal:  Hepatology       Date:  2018-11-08       Impact factor: 17.425

10.  Genetic analysis of hsCRP in American Indians: The Strong Heart Family Study.

Authors:  Lyle G Best; Poojitha Balakrishnan; Shelley A Cole; Karin Haack; Jonathan M Kocarnik; Nathan Pankratz; Matthew Z Anderson; Nora Franceschini; Barbara V Howard; Elisa T Lee; Kari E North; Jason G Umans; Joseph M Yracheta; Ana Navas-Acien; V Saroja Voruganti
Journal:  PLoS One       Date:  2019-10-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.